Phosphatidylinositol 4,5-bisphosphate (PI4,5P 2 ) is a key lipid signaling molecule that regulates a vast array of biological activities. PI4,5P 2 can act directly as a messenger or can be utilized as a precursor to generate other messengers: inositol trisphosphate, diacylglycerol, or phosphatidylinositol 3,4,5-trisphosphate. PI4,5P 2 interacts with hundreds of different effector proteins. The enormous diversity of PI4,5P 2 effector proteins and the spatiotemporal control of PI4,5P 2 generation allow PI4,5P 2 signaling to control a broad spectrum of cellular functions. PI4,5P 2 is synthesized by phosphatidylinositol phosphate kinases (PIPKs). The array of PIPKs in cells enables their targeting to specific subcellular compartments through interactions with targeting factors that are often PI4,5P 2 effectors. These interactions are a mechanism to define spatial and temporal PI4,5P 2 synthesis and the specificity of PI4,5P 2 signaling. In turn, the regulation of PI4,5P 2 effectors at specific cellular compartments has implications for understanding how PI4,5P 2 controls cellular processes and its role in diseases.
Introduction
Phosphatidylinositol 4,5-bisphosphate (PI4,5P 2 ) occupies a central position in phosphoinositide signaling, as it can be used as a substrate to produce other second messengers, or can directly regulate a wide range of cellular functions (Fig. 1 ). Nearly 60 years ago, Lowell and Mabel Hokin discovered the phosphatidylinositol (PI) cycle [1] , and soon after a series of discoveries revealed that PI could be sequentially phosphorylated on its myo-inositol ring to generate PI4,5P 2 [2] [3] [4] . At that time, PI4,5P 2 was thought to only serve as an intermediate in the PI cycle [5, 6] . Early studies identified a role for PI4,5P 2 as a precursor of other signaling molecules, such as inositol trisphosphate (IP 3 ) and diacylglycerol (DAG) [6] [7] [8] . In the 1980s, the role of PI4,5P 2 as a precursor was further expanded via the discovery that PI4,5P 2 could be used as substrate for PI3K to produce phosphatidylinositol 3,4,5-trisphosphate (PI3,4,5P 3 ) [9] .
In the mid 1980s, direct roles for PI4,5P 2 signaling were defined. Anderson and Marchesi discovered that PI4,5P 2 regulated the association of the cytoskeletal protein, band 4.1, with the membrane protein glycophorin, demonstrating a role for PI4,5P 2 in regulating the interaction of cytoskeletal proteins with the plasma membrane [10] . Lassing and Lindberg discovered that PI4,5P 2 directly interacts with, and inhibits, the actin-modifying proteins profilin and gelsolin, to promote actin assembly [11, 12] . These discoveries elevated PI4,5P 2 from simply being a precursor of messengers, to a lipid messenger in its own right ( Fig. 1) , and initiated an explosion of research on PI4,5P 2 -binding proteins/effectors. Currently, hundreds of PI4,5P 2 -binding proteins/effectors have been identified and this number is increasing. PI4,5P 2 effectors are distributed to diverse subcellular compartments and mediate distinct biological activities, including cell adhesion, cytoskeletal dynamics [13] , cell polarity [14] [15] [16] , secretion [17, 18] , ion channel regulation [19] , vesicular trafficking [20] , nuclear signaling, and gene expression [21, 22] (Fig. 1) .
There is now known to be a large and diverse array of PI4,5P 2 effectors, many of which are found in the same membrane compartment, e.g. the plasma membrane. This presents a dilemma, the cellular or membrane contents of most second messengers dramatically fluctuate upon agonist stimulation PIPK isoforms synthesize PI4,5P 2 
at distinct cellular locations
The PIPKI family is highly diverse. For example, there are at least six PIPKIg splice variants expressed in humans, labeled PIPKIgi1 to PIPKIgi6 [36, 37] using the HUGO (Human Genome Organization) nomenclature [36] . PIPKI isoforms all contain a highly homologous kinase core domain with invariant catalytic residues that bind ATP or GTP and Mg 2þ , and residues that recognize the specific lipid substrate [27, 38, 39] . There are three domains in the PIPKI isoforms that are sequence divergent: the N-terminal, kinase insert and the C-terminal domains [24] . These regions of sequence divergence define cellular targeting and functional interactions [24] . The PIPKIg splice variants emphasize this concept, as these isoforms have unique C-terminal sequence extensions from the PIPKIgi1 isoform [36] . The diversity of these sequences confers the ability to interact with different targeting proteins that are often PI4,5P 2 effectors. These enzymes are then targeted to specific cellular compartments where they generate PI4,5P 2 that specifically modulates effectors required for specific biological functions (Fig. 2) .
Consistently, each splice variant of PIPKIg localizes to select cellular locations. PIPKIgi2 can be targeted to focal adhesions by an interaction with talin [40, 41] . Conversely, PIPKIgi4 localizes to nuclear speckles and PIPKIgi5 is found at endosome compartments [36] . For historical reasons, the nomenclature for PIPKIa and PIPKIb in the literature is complicated by the fact that PIPKIa in mouse corresponds to PIPKIb in human and vice versa. To avoid confusion, we only use the human nomenclature when describing PIPKI isoforms in this review. PIPKIa is found at membrane ruffles [27] and nuclear Figure 1 . Overview of PI4,5P 2 functions in the cytosol and plasma membrane. PI4,5P 2 is a polyphosphoinositide that is phosphorylated on the 4th and 5th hydroxyl group on the myo-inositol ring. Its greatest concentration is seen on the plasma membrane but it is also found on most cellular membrane compartments and in the nucleus. PI4,5P 2 is utilized by PI3K or PLC to generate second messengers: PI3,4,5P 3 , DAG, and IP 3 . The generation of PI4,5P 2 in a spatio-temporal manner is the basis for PI4,5P 2 regulation of diverse cellular events, including endocytosis, exocytosis, vesicle trafficking, and cell migration.
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Where is PI4,5P 2 ?
The PI4,5P 2 -specific Pleckstrin homology (PH) domain from PLCd fused to GFP (PH-PLCd-GFP) has been used as a biosensor to examine the intracellular distribution of PI4,5P 2 [42] . Although it is clear that PIPKs are localized to multiple subcellular compartments and generate PI4,5P 2 at these sites [24, 33] , the PH-PLCd-GFP primarily detects PI4,5P 2 at the plasma membrane [42] . This observation is in conflict with the fact that many PI4,5P 2 effector proteins function at other compartments, such as focal adhesions, trafficking vesicles for integrin or E-cadherin, and the nucleus at sites of mRNA processing with Star-PAP [14, 16, 21, 31, 40, 43] , where the PH-PLCd-GFP does not localize [42] . These results indicate that PH-PLCd-GFP has a bias towards detection of plasma membrane PI4,5P 2 . It is possible that the levels of PI4,5P 2 at these other compartments are low and/or that the PI4,5P 2 generated there rapidly binds to effector proteins and cannot be detected by PLCd-PH-GFP, or that PLCd-PH-GFP access is prevented for steric reasons.
Besides the PLCd-PH-GFP, the cellular distribution of PI4,5P 2 beyond the plasma membrane has been demonstrated using other PI4,5P 2 -specific antibodies and probes. Using a purified GST-PLCd-PH, PI4,5P 2 was shown to be present at the plasma membrane, Golgi, endosomes, ER, and nucleus [44] .
Additionally, PI4,5P 2 -specific antibodies have been shown to localize to the plasma membrane as well as to intracellular compartments [45] . More recently, these antibodies were used to show the presence of PI4,5P 2 with PIPKIa and PIPKIb on autolysosomes to regulate autophagic lysosome reformation [46] . Finally, the development of a specific small molecular probe, PHDM, that mimics the PLCd PH domain, has the potential to expand our understanding of PI4,5P 2 function, by binding to and inhibiting PI4,5P 2 -regulated events, including endocytosis and stress fiber formation [47] .
Further evidence that PI4,5P 2 functions throughout the cell is that PIPK-interacting proteins are also often PI4,5P 2 effectors (Fig. 2) , such as talin and Exo70, which form direct interactions with PIPKIgi2 [16, 40, 48, 49] . Presumably, the localized synthesis of PI4,5P 2 by PIPKIgi2 modulates the function of effectors that are in close proximity, but without an obvious increase in PI4,5P 2 levels that are detectable by current approaches. This represents an area of vigorous investigation and debate in the field.
Local production of PI4,5P 2 regulates epithelial cell polarity and epithelial morphology Epithelial cells are an essential cell type of many organs, including kidney, lung, and vasculature, and typically these cells maintain apical and basolateral polarity. In vitro studies of epithelial cells in 3D culture indicate that maintenance of PI4,5P 2 and PI3,4,5P 3 at distinct regions of the plasma membrane is crucial for cyst formation during morphogenesis [50] . PI4,5P 2 concentrated at the apical region is important in promoting epithelial polarity through its recruitment of the scaffolding protein annexin-2, which then subsequently recruits the Cdc42 GTPase that binds to the Par6/aPKC complex [50] . The PTEN phosphatase is also recruited to the apical region to dephosphorylate PI3,4,5P 3 to PI4,5P 2 [50] . These findings indicate that PI4,5P 2 and PI3,4,5P 3 function as molecular identifiers of these plasma membrane compartments during epithelial morphogenesis, since changes in the distribution of these phosphoinositides alters the polarity and orientation of epithelial cells. For example, the delivery of exogenous PI4,5P 2 to the basolateral membrane is sufficient to induce a shift in proteins from apical to basolateral regions of the plasma membrane [50] .
Despite its differences from 3D culture, several key findings regarding epithelial cell polarity were made using traditional 2D cell culture. PIPKIgi2 has emerged as an important player in maintaining the epithelial polarity via E-cadherin trafficking [14, 15] (Fig. 3) . Simultaneous binding of PIPKIgi2 to E-cadherin molecules and the AP1B complex promotes E-cadherin transport to the basolateral surface to assemble adherens junctions. This process maintains epithelial polarity, while a loss of PIPKIgi2 inhibits E-cadherin transport to the basolateral membrane and disrupts epithelial polarity [14] . This dual interaction supports a mechanism in which the highly orchestrated genesis of PI4,5P 2 drives the assembly of the trafficking machinery with E-cadherin for specific trafficking to adherens junctions (Figs. 3 and 4). Alternatively, the interaction and coordination of PIPKIgi2 with the exocyst complex mediates E-cadherin delivery to the basolateral membrane to facilitate adherens junction assembly and the establishment of epithelial polarity [15] . Consistently, neuroepithelial cells from pan-PIPKIg knockout mice show clear defects in adherens junctions [51] . However, E-cadherin localization was normal in epithelial cells from other organs in PIPKIgi2 knockout mice [52] , indicating that there are compensatory mechanisms in vivo. Potentially, a role specifically for PIPKIgi2 may be less critical in 3D culture and in vivo.
PIPKIs regulate b-catenin transcriptional activity
b-Catenin is a component of adherens junctions that can interact with E-cadherin or actin. Free b-catenin can also enter the nucleus where it regulates transcription through its association with transcription factors [53] . Stimuli, such as growth factors, can lead to the disassembly of adherens junctions and also enhance b-catenin translocation to the nucleus for regulation of transcription [54, 55] . Intriguingly, PIPKIg was Figure 3 . PI4,5P 2 modulates E-cadherin trafficking. PIPKIg interacts with both E-cadherin and AP complexes. Through this dual interaction, PIPKIg acts as a scaffold between AP complexes and E-cadherin to facilitate E-cadherin endocytosis and trafficking to the basolateral membrane. In addition, AP complexes are PI4,5P 2 effectors. The localized generation of PI4,5P 2 via PIPKIg activates AP complexes. PIPKIg also modulates exocyst-mediated E-cadherin trafficking. PIPKIg generates local PI4,5P 2 pools on the basolateral membrane via interaction with E-cadherin, which direct the targeting of the exocyst. The direct interaction between the exocyst and PIPKIg further facilitates the recruitment of the exocyst to adherens junctions, where exocyst-bound lateral cargoes, such as E-cadherin, can be delivered.
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Prospects & Overviews .... recently found to also interact directly with b-catenin, independent of E-cadherin, and the increased expression of PIPKIg (similar to expression levels in breast cancers [56] ), but not a kinase dead form, was found to enhance b-catenin translocation to the nucleus and its transcriptional activity downstream of EGFR activation (Fig. 4) [57] . b-Catenin regulates a variety of target genes, including multiple genes that promote the epithelial to mesenchymal transition (EMT), such as Slug and ZEB1 [53, 58, 59] . During EMT, epithelial polarity is lost, and cells acquire a mesenchymal morphology. This role for PIPKIg in b-catenin-regulated transcription represents a unique role for PI4,5P 2 in regulating cell polarity. In normal epithelial cells, b-catenin transcriptional activity is limited by its interaction with E-cadherin and its degradation. The complex roles of PIPKIg-regulated signaling in controlling both epithelial polarity and transcriptional activities of b-catenin remain an area of uncertainty. Therefore, the role of PIPKIg and PI4,5P 2 in b-catenin nuclear translocation requires further characterization, including its function in epithelial and mesenchymal cell types and its activation by specific growth factors. PI4,5P 2 signaling regulates processes required for cell migration Figure 4 . PIPKIg regulates the assembly of E-cadherin into adherens junctions in polarized epithelial cells. Stimuli, such as growth factors, can promote disassembly and phosphorylation of adherens junction components. PIPKIg can promote nuclear translocation of b-catenin, leading to enhanced transcriptional activity. In migrating tumor cells, which have lost E-cadherin expression (after epithelial to mesenchymal transition, EMT), PIPKIgi2 coordinates with the exocyst complex and talin to mediate polarized delivery of integrins at the leading edge membrane. PI4,5P 2 generation by PIPKIgi2 in the plasma membrane or in recycling endosomes near the plasma membrane facilitates the assembly of the exocyst complex and talin. The coordinated activity of PIPKIgi2 and the exocyst complex in concert with talin at the leading edge promotes the polarized recruitment and trafficking of integrin molecules. Loss of PIPKIgi2, the exocyst complex or talin impairs the polarized recruitment/trafficking of integrins required for cell migration.
PI4
,5P 2 binds and/or regulates multiple actin-binding proteins, promoting cytoskeletal reorganization at leading edge lamellipodium [63, 64] . This includes reciprocal regulation between PIPKIs, small GTPases (RhoA, Rac1, and Cdc42), and PI4,5P 2 , during cell migration and in the targeting of signaling molecules to the plasma membrane [62, 66] . This phenomenon is illustrated in the N-WASP/Arp2/3 complex, where PI4,5P 2 directly binds to N-WASP to alleviate intramolecular constraints to activate the actin polymerization activity of Arp2/3 at leading edge lamellipodium [67] . Additionally, binding of both PI4,5P 2 and Cdc42 to distinct sites on N-WASP cooperatively activates the N-WASP/Arp2/3 complex required for cell migration [67, 68] . Finally, PI4,5P 2 -rich micro-domains promote and sustain protrusive motility via capturing and stabilizing the plus-end of microtubules, which is crucial for cell polarization and migration [69] .
Directionally migrating cells require the maintenance of cell polarity, polarized vesicle trafficking, and proper formation of a leading edge [16, 60] , which likely requires synergism between PI4,5P 2 and PI3,4,5P 3 [70] . These phosphoinositides mediate the polarized recruitment and activation of different signaling molecules at the leading edge [60, 66] . However, the specific enzymes and accessory molecules that maintain PI4,5P 2 and PI3,4,5P 3 at the leading edge of migrating cell require further characterization. This is especially important for understanding the specific functions of the rapid and transient increase of PI3,4,5P 3 in response to extracellular stimulation, even though PI4,5P 2 levels remain relatively constant. Potentially, this is accomplished by de novo PI4,5P 2 synthesis or an infusion from an adjacent compartment such as a secretory vesicle. Ongoing studies of these events will further elucidate the precise role of PI4,5P 2 generation and signaling in cell migration.
Focal adhesion assembly at the leading edge is an essential process in cell migration [13] , which requires the localized generation of PI4,5P 2 [40, 41, 71] . PIPKIgi2 is intensively linked with both integrin-and growth factor-stimulated cell migration [16, 31] . Polarized integrin trafficking and maintenance of cell polarity are essential for cell migration. PIPKIgi2 regulates these processes, through an interaction with the exocyst complex, a PI4,5P 2 -effector and vesicle trafficking protein complex, that is necessary for the delivery of integrins to the plasma membrane [16] (Fig. 4) . PIPKIgi2 also collaborates with talin to generate a localized PI4,5P 2 pool required for focal adhesion formation [40, 41] and this has been demonstrated by numerous studies showing defective cell adhesion and migration in PIPKIgi2 or talin knockdown cells [16, 31, 71] . The regulation of ''inside-out'' integrin activation by PIPKIgi2 and PI4,5P 2 is critical during cell migration. PI4,5P 2 induces the dissociation of the talin rod domain from its head domain and promotes the tethering of the talin head to PI4,5P 2 -enriched membranes, exposing a hidden integrin-binding interface that is required for integrin clustering [72] . Also, the talin FERM domain binds to an NPxY motif in the cytoplasmic domain of the integrin beta chain, leading to ''inside-out'' integrin activation [72, 73] . Paradoxically, PIPKIgi2 competes with integrins for talin binding [73] . However, the presence of an additional talin-binding site in the integrin beta chain, and the homo-dimeric nature of talin, potentially allow for the formation of a single complex through simultaneous binding of integrin and PIPKIgi2 to talin, which would regulate focal adhesion assembly and signaling in migrating cells [16, 72] . The role of PIPKIgi2 and talin in polarized secretion of integrin suggests that concentrated PI4,5P 2 could be delivered to the leading edge via secretory vesicles (Fig. 4) .
In addition to adherent cells, the roles of specific PIPKI isoforms and PI4,5P 2 signaling in regulation of chemotaxis and trans-endothelial migration has been extensively studied in non-adherent circulating leukocytes. PIPKIs and PI4,5P 2 signaling play critical roles in regulating uropods for leukocyte migration [61, 74] . Integrins recruit PIPKIgi2 in a polarized manner, leading to RhoA activation at uropods, which is required for neutrophil infiltration in vivo [61] . Similarly, PIPKIb is recruited to the cell rear by its unique C terminus, where it interacts with EBP50 and Rho-GDP to regulate cell polarity required for cell migration [74] . PIPKIg is also reported to play a role in neutrophil chemotaxis via regulating uropod retraction [65] . All of these studies further illustrate the importance of PI4,5P 2 in backness response/signaling required for cell migration, spatially distinct from PI4,5P 2 signaling at the leading edge. In these studies, overexpression of PIPKs may complicate the interpretation of the data, as in vivo synthesis of PI4,5P 2 may be spatially changed. Thus, studies employing only overexpression should be viewed with skepticism.
Endocytosis, exocytosis, and phagocytosis require PI4,5P 2 PI4,5P 2 signaling regulates the entry and exit of molecules at the plasma membrane from and to the extracellular space through endocytosis, exocytosis, and phagocytosis. The first step in endocytosis is the formation of the clathrin-coated pits that subsequently mature to form clathrin-coated endocytic vesicles [75] . PI4,5P 2 is a central component in the formation of clathrin-coated vesicles as it recruits various accessory molecules required for endocytic vesicle formation. These proteins include multiple phosphoinositide-binding proteins, such as the AP2 complex, AP180/CALM, epsin, Dab2, and HIP1/1R [75] . Importantly, precise tuning of PI4,5P 2 turnover is critical during endocytosis, e.g. the increase in PI4,5P 2 that coincides with clathrin coat assembly or the corresponding decrease in PI4,5P 2 for clathrin coat disassembly [76] . Paradoxically, neither PI4,5P 2 nor PI4,5P 2 -generating enzymes have been clearly observed on vesicle buds during clathrin-coat formation and maturation [75] . During late stages of endocytosis, the PI4,5P 2 phosphatases, OCRL and synaptojanin, are recruited to endocytic vesicles by direct interactions with clathrin and AP2, and subsequently reduce PI4,5P 2 levels, resulting in the dissociation of PI4,5P 2 effectors from endocytic vesicles, which is necessary for endosomal fusion [77, 78] .
Neuronal cells are commonly used to study how PI4,5P 2 signaling regulates communication across the synapse, through its precise control over endocytic and exocytic events [79] . PIPKIg is the predominant isoform for PI4,5P 2 synthesis in neuronal cells [30] . Following NMDA stimulation of neuronal cells, PIPKIgi2 is dephosphorylated by calcineurin, promoting the interaction of PIPKIgi2 with AP2 [80] .
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Prospects & Overviews .... This interaction enhances PIPKIgi2 kinase activity and, thus, the PI4,5P 2 generation that is necessary for endocytosis during neuronal cell activation [30, 80] . Similarly, the interaction of PIPKIgi2 with talin also regulates synaptic vesicle endocytosis, as inhibition of this interaction impairs endocytosis and exocytosis of synaptic vesicles [30] . This is further complicated by the phosphorylation status of the PIPKIgi2 C terminus, which dictates its ability to bind to either talin or the AP2 complex [81, 82] . However, the precise mechanism that determines specific interactions and its significance in endocytosis remains to be defined.
Similar to endocytosis, PI4,5P 2 regulates exocytosis in neuronal cells [83] . Exocytosis is especially important in neurons for the controlled release of neurotransmitters or hormones stored in secretory vesicles required for neuronal and hormonal communication [79] . Secretory vesicles docked near the plasma membrane are primed for rapid calciuminduced fusion and exocytosis [84, 85] . The membrane protein synaptotagmin-1, which is anchored on the surface of these synaptic vesicles, contains both calcium-and PI4,5P 2 -binding sites [85] . PI4,5P 2 binding induces a conformational change in synaptotagmin-1 that promotes fusion of the vesicle with the plasma membrane [85, 86] .
The study of bone marrow-derived macrophages obtained from PIPKIg and PIPKIa knockout mice has revealed a crucial role for both PIPKIg and PIPKIa in phagocytosis [32] . FcgR is important in regulating the phagocytosis of microbes by binding to immunoglobulins [87] . Loss of PIPKIg impaired attachment of IgG-opsonized particles and clustering of FcgR. More specifically, the PIPKIgi1 isoform induced actin depolymerization to promote the particle attachment necessary for FcgR microclustering. Further, Syk-mediated phosphorylation of PIPKIgi1 during FcgR-mediated phagocytosis promotes PIPKIgi1 enzymatic activity. In addition, formation of the actin-driven structures required for optimal binding to targets of phagocytosis depends on PI4,5P 2 , PI3,4,5P 3 , and active Rac1 [88] . Alternatively, it is possible that PIPKIa deficiency impairs particle ingestion without any effect on particle attachment. PIPKIa regulates particle ingestion by activating WASP and Arp2/3-dependent actin polymerization at the nascent phagocytic cup [32] .
Murine knockout studies demonstrate redundant and specific functions among PIPKIs
Although our precise understanding of tissue-specific expression of PI4,5P 2 -generating enzymes during embryonic development and postnatal life is lacking, genetic studies in mice indicate both redundant and distinct functions among PIPKIs (a, b, and g using the nomenclature for human PIPKIs) [89] . Knockout of PIPKIg in mice blocked embryonic development, resulting in prenatal death [30, 51] , whereas mice lacking PIPKIa or PIPKIb survive to adulthood with some functional defects in specific cell types [90, 91] . It is clear that each PIPKI isoform has a role in generating distinct PI4,5P 2 pools required for specific cellular processes, but functional redundancy among isoforms does exist [89, 90] .
Platelets from PIPKIa-knockout mice are deficient in PI4,5P 2 synthesis and IP 3 formation stimulated by thrombin [90] . PIPKIb is also involved in this process since double knockout of PIPKIa and PIPKIb led to a complete loss of thrombininduced IP 3 synthesis in platelets [90] . Although PIPKIg is the predominant PIPKI isoform in platelets, it does not appear to contribute to this process. Additionally, PIPKIa, but not PIPKIb, has a specific function in modulating platelet aggregation and in vivo thrombosis, further confirming the distinct roles of the different PIPKI isoforms [90] .
PIPKIb has been reported to negatively regulate mast cell functions and anaphylactic responses [91] . Knockout of PIPKIb in mice enhances passive cutaneous and systemic anaphylaxis, which may be due to the function of PIPKIb to negatively regulate FceRI-mediated cellular responses and anaphylaxis [91] . Interestingly, although depletion of PIPKIb decreases the total PI4,5P 2 level by about 15% in mast cells, the production of the PI4,5P 2 -derived second messengers IP 3 and PI3,4,5P 3 is increased [91] . This indicates that PIPKIb is not responsible for formation of PI4,5P 2 pools required for IP 3 and PI3,4,5P 3 production.
The majority of PI4,5P 2 in the brain is believed to be synthesized by PIPKIg [89] . Knockout of PIPKIg leads to a 30-50% reduction of PI4,5P 2 in the brain and causes synaptic transmission defects [30] , whereas knockout of PIPKIa or PIPKIb has no dramatic effect on levels of PI4,5P 2 in the brain [89] . Truncation of the PIPKIg gene in mice via deletion of exons 2-6, which encode most of the catalytic region, resulted in postnatal lethality within a single day, with mice displaying impaired motility and a lack of milk in their stomachs [30] . No other obvious anatomical anomalies were found in these mice, and the defects in nervous system function may have played an important role in their death [30] . Interestingly, another independent PIPKIg-knockout mouse line, generated by inserting a b-geo gene trap within the first intron of the PIP5KIg gene, failed to develop beyond embryonic day 11.5, and these embryos had defects in myocardial development and neural tube closure [51] . The cause for the differences between these two knockout mouse lines remains unclear and may reflect the different genetic backgrounds or knockout approaches.
PIPKIg has different splice variants and each variant can play distinct roles [24, 36] . While depletion of pan-PIPKIg is lethal [30, 51, 52] , mice with the specific knockout of PIPKIgi2 develop normally, and are indistinguishable from wild-type littermates [52] . This indicates that PIPKIg activity, but not PIPKIgi2 is required for normal embryonic development. However, both pan-PIPKIg-and the PIPKIgi2-knockout mice show defects in synaptic vesicle endocytosis, suggesting a specific and non-redundant role for PIPKIgi2 in this process [52] . Agonist-induced Ca 2þ signaling is reduced in pan-PIPKIgknockout mice and enhanced in PIPKIgi2-knockout mice, indicating distinct roles of PIPKIg variants in Ca 2þ signaling [52] .
PI4,5P 2 -regulating enzymes are associated with human diseases
Until now, only one disease-causing mutation has been reported for PIPKI genes. Genetic mutation in PIPKIg (D253N) [92] . Homozygosity of this mutation is lethal postnatally with respiratory insufficiency, fetal akinesia, limb contractures, and muscle atrophy [92] . These defects may be caused by disruption of PIPKIg activity, leading to a defect of PI4,5P 2 synthesis in the brain and neurological malfunction [92] . A potential link between PI4,5P 2 signaling and Alzheimer's disease was identified over two decades ago, where a reduced phosphoinositide content, including PI4,5P 2 , in the temporal cortex was suggested to impair receptor function in Alzheimer's disease [93, 94] . Consistently, genetic mutations in presenilin1 and presenilin2 that cause familial Alzheimer's disease perturb PI4,5P 2 metabolism, which affects calcium currents and the biogenesis of amyloid-b-peptide [95, 96] . Further, treatment of primary cortical neurons with amyloid-b-peptide decreased PI4,5P 2 levels and caused synaptic dysfunction [93, 96] . The amyloid-b-peptide-induced synaptic dysfunction was ameliorated by maintaining normal PI4,5P 2 levels in the brain [93] .
The importance of PI4,5P 2 homeostasis is also evident in Lowe syndrome. Individuals with this condition exhibit several abnormalities, including cataracts, mental retardation, and defects in kidney function. The disease is caused by mutations in the Ocrl1 gene, which encodes a PI4,5P 2 5-phosphatase. Multiple different nonsense and missense mutations have been identified that result in truncated, degraded, or nonfunctional forms of the enzyme [78, 97] . A wide range of cellular defects have been identified in patients with Lowe syndrome. For example, loss of OCRL function causes ectopic accumulation of PI4,5P 2 on early endosomes, which impairs the recycling of multiple receptors including megalin [78, 97] . This defect in megalin recycling in renal proximal tubular cells impairs the retrieval of proteins from kidney ultrafiltrates, which would contribute to the kidney dysfunction in patients with Lowe syndrome. These phenotypes indicate that aberrant generation or turnover of PI4,5P 2 impacts normal function and leads to human diseases.
Summary and perspectives
PI4,5P 2 is one of the most utilized signaling molecules in eukaryotic cells. Diverse PIPKs are targeted to distinct subcellular compartments via their targeting factors to establish specific local PI4,5P 2 pools. These modulate the activity of PI4,5P 2 effectors to mediate a vast array of biological functions. The discovery of an increasing number of new PIPK isoforms and splice variants, targeting factors, and novel PI4,5P 2 effectors will expand our knowledge of PI4,5P 2 biological functions. However, understanding the exact roles for PI4,5P 2 signaling poses an enormous challenge due to the dynamic nature of PI4,5P 2 , the varying affinities and specificities of protein-lipid interactions, the diversity of PI4,5P 2 -generating and -utilizing enzymes, and their mechanisms of regulation [98] .
PI4,5P 2 can be utilized as a precursor to generate other phosphoinositides such as PI3,4,5P 3 and PI4P. How the specific local PI4,5P 2 pools affect the production of other phosphoinositides and modulate their signaling still needs to be clarified. In addition, some PI4,5P 2 effectors also interact with, and are modulated by, additional phosphoinositide species. The specific roles of PI4,5P 2 and its cooperativity with other phosphoinositides to modulate these effectors should be elucidated in future studies.
Continuing research is necessary to further understand how PI4,5P 2 signaling functions in novel cellular pathways, and how these processes relate to known PI4,5P 2 -associated diseases. To accomplish this, it will be necessary to determine the expression of distinct PIPKs in pathological conditions, and further characterize the cellular localization of newly discovered isoforms and splice variants. Additionally, the identification of PI4,5P 2 effectors will further explain how the unique distributions of PI4,5P 2 can regulate specific processes. The characterization of animals with a knockout of specific PIPK splice variants or PI4,5P 2 effectors will be important in determining the specific defects associated with each isoform and the associated effectors that mediate these pathways. It will be important to study knockout mice to define phenotypes that relate to neuronal diseases, cancer metastasis, and cardiovascular diseases. This will further our understanding of how PI4,5P 2 can broadly regulate cellular functions with potential consequences in pathological conditions.
